Diabetes technology & therapeutics
-
Diabetes Technol. Ther. · Nov 2012
Comparative StudyComparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery.
Continuous intravenous insulin infusion (CII) following coronary artery bypass graft (CABG) surgery reduces postoperative complications and hospitalization duration. Because of limited data evaluating outcomes of CII with revised glycemic targets (110-140 mg/dL) in cardiac surgery, this study compared efficacy and safety of two different CII protocols having revised targets. ⋯ CII protocols targeting 110-140 mg/dL were effective in achieving revised targets with low hypoglycemia. Despite differences in mean BG level and time to target, each hospital continued using its existing protocols and identified areas for improvement.